Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.46 |
| ▸ | CTSV | O60911 | 1/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28746601 | 1.00 | HSD17B10 (0.46) | HSD17B10ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL3142147 | 1.00 | HSD17B10 (0.46) | HSD17B10ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL28095643 | 0.99 | HSD17B10 (0.45) | HSD17B10ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL30273419 | 0.99 | HSD17B10 (0.45) | HSD17B10ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL17600561 | 0.99 | HSD17B10 (0.45) | HSD17B10ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL27551421 | 0.99 | HSD11B1 (0.47) | HSD17B10ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL10460557 | 0.94 | HSD11B1 (0.46) | HSD17B10ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL13169298 | 0.90 | ALDH1A1 (0.42) | HSD17B10ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL3142406 | 0.88 | PDE10A (0.48) | HSD17B10ALDH1A1KDM4EMAPTRAB9A | |
| Acetoacetic Acid SCHEMBL29708957 | 0.86 | TRPV1 (0.40) | ALDH1A1MAPTRAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111836816-B | Aniline derivatives and use thereof | 日产化学株式会社 | 2023-12-19 | — | — | CN | disclosed |
| CN-116193960-A | Aniline derivatives and use thereof | 日产化学工业株式会社 | 2023-05-30 | — | — | CN | disclosed |
| CN-107428676-B | Aniline derivative and use thereof | 日产化学工业株式会社 | 2022-11-08 | — | — | CN | disclosed |
| CN-108884016-B | Arylamine derivatives and use thereof | 日产化学株式会社 | 2022-11-01 | — | — | CN | disclosed |
| EP-3571730-B1 | LIGHT-EMITTING ELECTROCHEMICAL CELL, METHOD FOR PRODUCING AND METHOD FOR OPERATING SAME | LUNALEC AB (SE) | 2022-09-21 | — | — | EP | disclosed |
| CN-110437046-B | Fluorine atom-containing polymer and field of use thereof | 日产化学工业株式会社 | 2022-08-16 | — | — | CN | disclosed |
| CN-110268541-B | Charge-transporting varnish | 日产化学株式会社 | 2022-08-09 | — | — | CN | disclosed |
| CN-109563243-B | Fluorine atom-containing polymer and use thereof | 日产化学株式会社 | 2022-07-08 | — | — | CN | disclosed |
| EP-3249710-B1 | CHARGE-TRANSPORTING VARNISH, CHARGE-TRANSPORTING FILM, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NISSAN CHEMICAL CORP (JP) | 2019-11-13 | — | — | EP | disclosed |
| CN-106660939-B | Charge-transporting varnish | 日产化学工业株式会社 | 2019-11-12 | — | — | CN | disclosed |
| EP-1881050-A2 | Luminescence device and display apparatus | Canon Kabushiki Kaisha (JP) | 2008-01-23 | — | — | EP | disclosed |
| US-20070216294-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070212570-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2007-09-13 | — | — | US | disclosed |
| US-7147935-B2 | Such as tetrakis(1-(5-heptyloxyphenyl)isoquinoline-C2,N) (pu-dichloro) iridium (III); for red luminescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2006-12-12 | — | — | US | disclosed |
| CN-1285601-C | Light emitting device and display | CANON KK (JP) | 2006-11-22 | — | — | CN | disclosed |
| US-20060177694-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2006-08-10 | — | — | US | disclosed |
| CN-1781925-A | Luminescence device and display apparatus | CANON KK (JP) | 2006-06-07 | — | — | CN | disclosed |
| CN-1474826-A | Light emitting device and display | ������������ʽ���� | 2004-02-11 | — | — | CN | disclosed |
| EP-1348711-A1 | LUMINESCENT ELEMENT AND DISPLAY | CANON KABUSHIKI KAISHA (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-20030068526-A1 | Such as tetrakis(1-(5-heptyloxyphenyl)isoquinoline-C2,N) (pu-dichloro) iridium (III); for red luminescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060177694-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | AP3M1, MLEC, MLX | HSD17B10 4838/4885ALDH1A1 4094/4885KDM4E 3317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.